InVivoMAb anti-mouse PD-1 (CD279)

Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8+ T Cells. Li J et al., 2018 Apr 17, Immunity

Cutting Edge: PD-1 Regulates Imiquimod-Induced Psoriasiform Dermatitis through Inhibition of IL-17A Expression by Innate gammadelta-Low T Cells. Imai Y et al., 2015 Jul 15, J Immunol

ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy. Li C et al., 2015 Jun, EMBO Mol Med

Intratumoral administration of mRNA encoding a fusokine consisting of IFN-beta and the ectodomain of the TGF-beta receptor II potentiates antitumor immunity. Van der Jeught K et al., 2014 Oct 30, Oncotarget

Blockade of LFA-1 augments in vitro differentiation of antigen-induced Foxp3+ Treg cells. Verhagen J et al., 2014 Dec 1, J Immunol Methods

Impaired selectin-dependent leukocyte recruitment induces T-cell exhaustion and prevents chronic allograft vasculopathy and rejection. Sarraj B et al., 2014 Aug 19, Proc Natl Acad Sci U S A

Differential kinetics of antigen dependency of CD4+ and CD8+ T cells. Rabenstein H et al., 2014 Apr 15, J Immunol

Negative role of inducible PD-1 on survival of activated dendritic cells. Park SJ et al., 2014 Apr, J Leukoc Biol

The immunocytokine L19-IL2 eradicates cancer when used in combination with CTLA-4 blockade or with L19-TNF. Schwager K et al., 2013 Mar, J Invest Dermatol

Reviving function in CD4+ T cells adapted to persistent systemic antigen. Noval Rivas M et al., 2009 Oct 1, J Immunol